Searched for
PATENT NORM VIOLATIONS
Air India embraces AI to enhance ops efficiency, increase revenues, reduce costsAir India is embracing artificial intelligence to transform its operations. The airline is using AI to cut costs, improve customer service ...- Outrageous violation of liberty: P Chidambaram on Delhi Police 'forcibly' entering AICC HQThe Congress alleged that some Delhi Police personnel forcibly entered its headquarters and beat up party workers and leaders on Wednesday,...
- Delhi High Court notice to government over MNCs' patent disclosureThe petition exposes the weak enforcement of an important statutory provision, Form 27, which discloses patent data of a company.
- Indian patent law very strong, at par with global standards: MarutiAmerican pharma sector had alleged that Indian IPR laws discriminate against US companies and violate global norms.
- Cipla bats for 'essential' medicines being made available to people at affordable ratesDrug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly...
- India rejects US allegations; says IPR regime WTO compliantIndia today asserted that its laws are fully compliant with international agreements and the country has never deviated from global practic...
- Competition Comm to now probe Ericsson on Intex complaintActing against Ericsson for the second time in as many months, the Competition Commission has issued another order for probing allegations.
- Government mulls stricter norms for patents in pharma spaceThe Indian Patent Office is considering a proposal that seeks to make it mandatory for drug firms to disclose the WHO-assigned generic name...
- Individual cases to dictate MNC drug cos’ approach to patentsRoche’s decision to give up India patent for Herceptin unlikely to set a precedent, says MNC drug companies’ body.
- Generic business may hit drug exports of Indian firms like Cipla and NatcoIndia exported medicines worth $13.2 billion last fiscal and the government plans to double it to $25 billion by March 2014.
- US accuses India of WTO rules violation over Nexavar: ReportThe government had defended the move, with Commerce and Industry Minister Anand Sharma stating that India did not violate any WTO norms.
- Watson starts selling generic Lipitor in US, Ranbaxy mumUS-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...
- Govt plans to make public details of patented drugsA generic drugmaker can seek 'compulsory licensing', a provision that allows generic company to legally make and sell cheaper version of th...
- Non-compliance with disclosure norms on patents may bring trouble for pharma companiesSeveral global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...
- India may file case against EU at WTOIndia is likely to file an official case against the European Union asking the World Trade Organisation to bring EU customs regulations in ...
- Drugmakers criticise Mashelkar committee's reportThe commerce ministry’s decision to accept the Mashelkar committee’s revised report that recommends not to restrict patenting to new drugs ...
- Govt won't tweak drug patent rulesEarlier this month, the ministry accepted the controversial report, first released in 2007 but withdrawn over allegations of plagiarism and...
- India to prepare case on drug confiscations at European portsIndia is preparing its case on the repeated seizures at European ports of its consignments containing off-patent drugs meant for other deve...
- India may drag EU to WTO on seizure of drugs in transitIf the European Union does not allow Indian drugs to transit through its customs even after bilateral negotiations, India will drag Brussel...
- How will amendments to Patents Bill help pharma?The amendments address the demands for making the law more friendly to the domestic pharmaceutical industry, while meeting international ob...
Load More
